News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|September 15, 2020

Top 12 Mistakes in Perinatal Psychiatry

Author(s)Jennifer L. Payne, MD

Although they may have been the result of good intentions, these mistakes could adversely impact mother and baby.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

SockaGPhoto

Rational Off-Label Prescribing: A Review With Joseph F. Goldberg, MD, and Henry Nasrallah, MD

ByJoseph F. Goldberg, MD,Henry Nasrallah, MD

April 23rd 2026

medication adherence psychiatry

Beyond Compliance: A Patient-Centered Approach to Psychopharmacological Adherence

ByJoseph F. Goldberg, MD,Martha Sajatovic, MD

April 22nd 2026

pregnancy

Podcast: Depression, SSRIs, and Pregnancy. Getting to the Truth With Marlene P. Freeman, MD

ByJoseph F. Goldberg, MD,Marlene P. Freeman, MD

April 17th 2026

lithium

Management of Lithium’s Adverse Effects: Update on Weight Gain

ByDavid N. Osser, MD

April 17th 2026

tinnitus

Tinnitus Associated With Bupropion: The Importance of Dosage Adjustment

ByMurtaza Khan, MD,James A. Bourgeois, OD, MD

April 15th 2026

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Beyond Compliance: A Patient-Centered Approach to Psychopharmacological Adherence

EMP-01 for Social Anxiety Disorder Demonstrates Meaningful Improvements in Phase 2a Study

Rational Off-Label Prescribing: A Review With Joseph F. Goldberg, MD, and Henry Nasrallah, MD

Psychedelics Deserve Real Science

Prolactin Monitoring for Antipsychotics and the Impact of Stress